Join
Live feed
·
PRReleasevia Quantisnow
Dianthus Therapeutics Inc. logo

Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

ByQuantisnow·Wall Street's wire, on your screen.
DNTH· Dianthus Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DNTH (Dianthus Therapeutics Inc.) and more on Quantisnow.